Home » Authors » Jim Shrine

Articles by Jim Shrine

Swiss Firm GlycoVaxyn Raises $9.5M For Vaccine Programs

July 17, 2007

Swiss Firm GlycoVaxyn Raises $9.5M For Vaccine Programs

July 17, 2007

CODA Raises $7M In Series C For Protein Expression Platform

July 12, 2007

CODA Raises $7M In Series C For Protein Expression Platform

July 12, 2007

CureVac Completes €35M Round For mRNA Product Development

July 11, 2007

CureVac Completes 35M Round For mRNA Product Development

July 11, 2007

No Abstract

Reata Raises $25M In Series E To Fund Development Programs

July 9, 2007

Reata Raises $25M In Series E To Fund Development Programs

July 9, 2007

ViroPharma Starts Phase III Trial Of Camvia In Liver Transplants

July 6, 2007

ViroPharma Starts Phase III Trial Of Camvia In Liver Transplants

July 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 11, 2024.
Boryung invests $10M in Intuitive Machines for outer space R&D
BioWorld
Following its $60 million investment in Axiom Space Inc. last year, Boryung Co. Ltd. made a $10 million private placement in Intuitive Machines Inc. to grow its...
Phase II Huntington’s tie-up with Novartis could edge $3B for PTC
BioWorld
PTC Therapeutics Inc. said a “highly competitive process with several parties involved” led to the deal centered on the firm’s Huntington’s disease program with...
Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal
BioWorld
Elevar Therapeutics Inc. will license Relay Therapeutics Inc.’s “NDA-ready” bile duct cancer therapy, lirafugratinib (RLY-4008), through a potential $500 million...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.